Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study
Die Rolle des Aspergillus-Galaktomannan-Antigens zur Einschätzung des Risikos akuter Exazerbationen bei Patient:innen mit chronisch obstruktiver Lungenerkrankung: eine Querschnittsstudie
Monaldi Archives for Chest Disease · 12.09.2024 · 95 (3)
DOI: 10.4081/monaldi.2024.3041 ↗Auf einen Blick
Bei 61 COPD-Patient:innen zeigte Serum-Galaktomannan nur eine begrenzte diagnostische Aussagekraft für das Exazerbationsrisiko. Die Sensitivität war niedrig, die Spezifität höher.
Fragestellung
Welche Rolle hat Aspergillus-Galaktomannan im Serum für das Risiko akuter Exazerbationen bei COPD und wie gut ist der diagnostische Nutzen?
Methode
Querschnittsstudie bei COPD-Patient:innen ab 40 Jahren; Analyse von Serum-Galaktomannan und Aspergillus-spezifischen Antikörpern sowie klinischen Daten; ROC-Analyse.
Ergebnisse
Unter 61 rekrutierten COPD-Patient:innen waren 24,5 % galaktomannan-positiv. AUC 0,6027; Sensitivität 44,4 %, Spezifität 83,7 % bei Cut-off 0,5. Assoziationen mit Hämoptyse und früherer Tuberkulose.
Schlussfolgerung der Autor:innen
Serum-Galaktomannan-Antigen zeigte nur eine begrenzte Sensitivität; ein Routinetest zur Vorhersage des Exazerbationsrisikos könnte laut Autor:innen nicht gerechtfertigt sein.
Kernaussagen
- 24,5 % der 61 COPD-Patient:innen waren galaktomannan-positiv
- AUC 0,6027; Sensitivität 44,4 %, Spezifität 83,7 %
- Assoziationen mit Hämoptyse und früherer Tuberkulose
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Querschnittstudie in der Zeitschrift Monaldi Archives for Chest Disease, online erschienen am 12.09.2024. Verfasst von Jayabharathi Palanivel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Mannans, Aspergillus, Antigens, Fungal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is characterized by permanent airflow obstruction due to abnormalities of the airways and alveoli. This study investigated the potential role of Aspergillus species in acute exacerbations of COPD (AE-COPD) and evaluated the diagnostic utility of serum Aspergillus galactomannan antigen. This cross-sectional study, carried out at the Jawaharlal Institute of Postgraduate Medical Education and Research from January 2021 to June 2022, involved COPD patients aged ≥40 years. Serum galactomannan and serum Aspergillus-specific antibodies were analyzed, along with the collection of demographic details, symptoms, and comorbidities. Statistical analyses, including univariate analysis and receiver operating characteristic (ROC) curve analysis, were performed. Among the 61 recruited COPD patients, 24.5% showed serum galactomannan positivity. Significant associations were found between galactomannan positivity, hemoptysis, and previous tuberculosis. ROC analysis revealed modest diagnostic accuracy (area under the ROC=0.6027) with a sensitivity of 44.4% and a specificity of 83.7% at a cut-off of 0.5. Univariate analysis did not show any potential links between diabetes, hypertension, previous exacerbations, and severe Global Initiative for Chronic Obstructive Lung Disease stages with a risk of exacerbation. Serum galactomannan antigen showed limited sensitivity, and its routine testing may not be justified for predicting exacerbation risk. Further studies are warranted to validate these findings and explore other diagnostic methods using bronchoalveolar lavage galactomannan antigen in AE-COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry.
- Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry.
- Department of Radiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry.
- Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry.
ORCID-Profile: Jayabharathi Palanivel, Debasis Gochhait, Rakesh Singh
Zitieren
APA
Palanivel, J., Mohapatra, M. M., Rajaram, M., Gochhait, D., Chakkalakkoombil, S. V., & Singh, R. (2024). Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study. Monaldi Archives for Chest Disease, 95(3). https://doi.org/10.4081/monaldi.2024.3041
Vancouver
Palanivel J, Mohapatra MM, Rajaram M, Gochhait D, Chakkalakkoombil SV, Singh R. Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study. Monaldi Archives for Chest Disease. 2024;95(3). doi:10.4081/monaldi.2024.3041
BibTeX
@article{Palanivel2024,
author = {Palanivel, Jayabharathi and Mohapatra, Madhusmita Mohanty and Rajaram, Manju and Gochhait, Debasis and Chakkalakkoombil, Sunitha Vellathussery and Singh, Rakesh},
title = {Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study},
journal = {Monaldi Archives for Chest Disease},
year = {2024},
volume = {95},
number = {3},
doi = {10.4081/monaldi.2024.3041}
}
EUVIMED